as 12-20-2024 3:44pm EST
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Founded: | 1952 | Country: | United States |
Employees: | N/A | City: | PARSIPPANY |
Market Cap: | 80.4B | IPO Year: | 2013 |
Target Price: | $220.33 | AVG Volume (30 days): | 2.4M |
Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 5.32 | EPS Growth: | 8.38 |
52 Week Low/High: | $144.80 - $200.53 | Next Earning Date: | 02-11-2025 |
Revenue: | $9,152,000,000 | Revenue Growth: | 9.33% |
Revenue Growth (this year): | 9.41% | Revenue Growth (next year): | 4.70% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Polzer Robert J | ZTS | Executive Vice President | Nov 25 '24 | Sell | $177.46 | 3,477 | $617,028.42 | 3,249 |
ZTS Breaking Stock News: Dive into ZTS Ticker-Specific Updates for Smart Investing
Zacks
19 hours ago
Zacks
a day ago
Motley Fool
2 days ago
The Wall Street Journal
4 days ago
Zacks
5 days ago
Simply Wall St.
6 days ago
Zacks
8 days ago
Motley Fool
8 days ago
The information presented on this page, "ZTS Zoetis Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.